Berkeley Lights Inc. is a biotechnology company that specializes in developing and providing innovative solutions for the acceleration of cell-based research and development. Founded in 2011 and headquartered in Emeryville, California, the company has gained recognition for its pioneering technologies that enable the manipulation and analysis of individual cells at a rapid pace.
Central to Berkeley Lights' offerings is its proprietary platform known as the Beacon and Lightning systems. These systems utilize microfluidics, optoelectronics, and advanced software to automate and streamline various processes related to cell analysis, screening, sorting, and characterization. This platform enables researchers to study and manipulate individual cells with precision, making it a valuable tool for various applications in biopharmaceuticals, immunology, and genomics.
One of the key features of Berkeley Lights' technology is its ability to perform thousands of experiments simultaneously and in real-time, allowing researchers to quickly gain insights into cell behavior, drug interactions, and disease mechanisms. This speed and efficiency are particularly crucial in the development of novel therapies and the discovery of new drug candidates.
The company's platform has widespread applications across the life sciences industry, including cell line development, antibody discovery, and immune cell profiling. By providing researchers with a powerful tool to analyze and understand cellular biology at a high throughput, Berkeley Lights contributes to accelerating scientific advancements and improving healthcare outcomes.
Berkeley Lights' commitment to innovation is reflected in its continuous efforts to improve its platform's capabilities and expand its offerings. The company collaborates with various biopharmaceutical and research institutions to develop custom solutions tailored to specific research needs.